Interstitial fluid pressure in intracranial tumours in patients and in rodents. - Wikidata - wikimedia - TriplyDB

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

http://www.wikidata.org/entity/Q36116465

about

Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide.Developmental and pathological angiogenesis in the central nervous system Subarachnoid space: new tricks by an old dog Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)Towards the Personalized Treatment of Glioblastoma: Integrating Patient-Specific Clinical Data in a Continuous Mechanical Model Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.Interstitial fluid flow in cancer: implications for disease progression and treatment.Normalization of the vasculature for treatment of cancer and other diseases.Effect of brain tumour laterality on patients' perceived quality of life.Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.Compression stiffening of brain and its effect on mechanosensing by glioma cells Peritumoral tissue compression is predictive of exudate flux in a rat model of cerebral tumor: an MRI study in an embedded tumor.Perfusion MRI of U87 brain tumors in a mouse model.VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors Local endostatin treatment of gliomas administered by microencapsulated producer cells.High interstitial fluid pressure is associated with low tumour penetration of diagnostic monoclonal antibodies applied for molecular imaging purposes.A multiscale model for avascular tumor growth.Development of novel targeted therapies in the treatment of malignant glioma.Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors.Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia.Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.Implications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors.Odyssey of a cancer nanoparticle: from injection site to site of action.Convection-enhanced delivery in the treatment of malignant glioma.MRI measurement of change in vascular parameters in the 9L rat cerebral tumor after dexamethasone administration Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer.Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Engineering strategies to mimic the glioblastoma microenvironment.The concordance of MRI and quantitative autoradiography estimates of the transvascular transfer rate constant of albumin in a rat brain tumor model Cell-ECM Interactions in Tumor Invasion.Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery.Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival.Elastographic Assessment of Xenograft Pancreatic Tumors.T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.Quantitative Molecular Imaging with a Single Gd-Based Contrast Agent Reveals Specific Tumor Binding and Retention in Vivo.

P2860

Q26999332-4BDB2855-2B79-4B67-8939-C0D04D772740 Q27010580-C86BCC8F-23C2-4240-ADCA-F6E76CD91756 Q27023250-A3A720EB-6E0A-45B2-B750-66E15DEB3893 Q28729003-59CD8316-20E9-41F7-9057-4E4522E6EF93 Q28732214-FFFD6AC9-07A5-4BF5-B740-6C5C161DB6FC Q30000060-19B2A9E4-E436-4C2E-9F49-3B180CAD59B3 Q30275623-EE52D514-55B0-49BD-8C8C-3D8487E70C90 Q30411142-86699DC0-B476-4EC9-AD1F-D88AB49F7BF6 Q30471456-FE68831C-B875-4A22-88AB-6D81A3074EC3 Q30495503-0E13B8F7-E15E-4D4C-954B-01BF93175E54 Q30542073-93F34033-06C2-4BBA-8852-0F60B5FE22C2 Q30634187-C15F7435-5E8B-4B86-B4AE-C6727EC73CEB Q30680915-DCE074A8-8700-40C8-8CBC-75BD96F0FAD9 Q30927721-C44271BD-83B8-4F24-B381-1EA594B27CCA Q33424301-82926F9A-FDF3-4BC6-8B61-EBBB6147F07C Q33697847-E5BE515A-AC82-4AE7-A4FB-E6C2CA34F9F1 Q33929689-D7A4565B-651C-48A8-A638-642DE47FD16C Q34270696-996F2B03-3BDF-4F1B-9D07-243248A45803 Q34352400-FC564206-4CE5-4C66-8D9A-06B90D1C750E Q35770177-B0E06183-9FA7-4457-91E9-BC63BD1B6F74 Q35820046-F75C5E63-0201-41FF-A0E3-F460044E1303 Q35990065-E8E7BD1C-58AD-4A5F-8BF2-609148F3C495 Q36064914-FB11ACC9-22D7-451B-9FB8-434BB07CBCE1 Q36368541-92C859F4-EE9D-489A-8AC2-52F9F2131651 Q36459196-F83C89B2-1AA0-40D5-A9A6-C4046CC55693 Q36523379-F85505F2-9AEA-4969-827E-DEBDFBA3EC8D Q36955458-B21A37AC-CC90-4349-B8E3-80BCECA75BF0 Q37109214-BAA1B523-73A3-44AC-A88A-B797A47B7D90 Q37159509-DA04C909-65B7-478C-AECE-BC27E6B3AFEB Q37501552-507CBC7C-ADB4-4D62-922B-0891FCADE38E Q37995554-9787E08C-8C4A-4332-8CBA-0C8F957C119B Q38244936-C503FECF-663D-43C4-A2BF-98766CC8E825 Q38295979-1145E07D-9D95-47D0-976C-86E41306C53B Q38980083-5AB5589A-15CF-4417-BD63-D70B287C027C Q42364589-B12E2F8C-DF4D-4328-921F-45B635920AB8 Q42785240-74C5BC54-E95D-4A3B-99F6-2C1FD7AAA1A0 Q44503283-A2AA27C3-F281-4946-939C-8C1BA60FF451 Q47614745-E1A7A15D-81D6-4816-BBF5-79AF949719A8 Q47832897-4E720716-2129-4804-8E17-B023E82A5735 Q48178834-4AE9B37E-5C2B-4B64-8546-FFA7B1A767A6

P2860

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

http://www.wikidata.org/entity/Q36116465

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

@ast

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

@en

type

label

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

@ast

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

@en

prefLabel

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

@ast

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

@en

P1433

Q36116465-311AE5D1-C875-4B26-96D9-96821A92A51A

P1476

Q36116465-807AFB59-7BFC-4235-840B-4B400A2FEE38

P2093

Q36116465-0BD00498-5CB8-407A-B874-CEEDC3B765ED

Q36116465-13640BA1-78F6-46DA-AF52-788B44976A95

Q36116465-260EB991-1EB4-4A7C-A664-92C4903082CA

Q36116465-A5ACF664-31E1-4362-B050-2DC67B02A97B

Q36116465-C5A20E11-CA2A-43A8-8BF6-F0A55C234184

P2860

Q36116465-085E05F9-68EF-4477-9358-1B38C8517E4F

Q36116465-0E480FB0-3F77-469E-BE39-94617249466B

Q36116465-1294FBA2-D864-4F8F-8143-2F7F41FE1C37

Q36116465-1AD45968-7E46-4F5A-99B7-94D2D0EBF6B6

Q36116465-1DF57CA2-3AB9-4941-A152-1B46C96E2C63

Q36116465-24D915BA-ED39-4F33-B543-B4054D43FBB5

Q36116465-26804FDC-4CA1-4082-A7D4-13002A42DB2D

Q36116465-27523230-BDC3-485A-AE7F-F419927C2BE6

Q36116465-2C5A6365-F492-4A6B-AB8C-0914AEB2755D

Q36116465-2DA4523F-761D-424B-B749-5D1653DA0105

P2888

Q36116465-03208031-9796-45A7-AA9B-A8551BC12661

P304

Q36116465-3B27EB27-E323-447D-9DC5-C37BFD346F8B

P31

Q36116465-89C74C85-7A11-4A88-9110-3CB993BBB8A4

P356

Q36116465-EDDCDA40-40E2-4EFA-B2EC-40C638D8F6C1

P407

Q36116465-C5334B2B-0559-4D69-A37C-661DA4DDABE6

P433

Q36116465-24DD77C3-8133-4961-85F2-B18301B66BDC

P478

Q36116465-933D504A-3F01-48FF-8AEB-842B4FCC1E2E

P577

Q36116465-7A051895-C293-4EA1-8B0C-366B09686C14

P5875

Q36116465-51B257CE-F9FD-42DD-903F-E7FEA533D192

P6179

Q36116465-242BAAA3-7B34-45FD-BC83-E92C02FCEC5E

P698

Q36116465-0087F000-6408-4C72-AEBC-C0BEF82E53E7

P932

Q36116465-52FCA31B-638A-4225-9D83-7D2DB39F35E7

P356

P1433

British Journal of Cancer

P1476

Interstitial fluid pressure in intracranial tumours in patients and in rodents.

@en

P2093

B Witwer

http://www.w3.org/2001/XMLSchema#string

G R Harsh

http://www.w3.org/2001/XMLSchema#string

H Salehi

http://www.w3.org/2001/XMLSchema#string

R K Jain

http://www.w3.org/2001/XMLSchema#string

Y Boucher

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications.

Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone.

Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure.

Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection.

The effect of large doses of dexamethasone on the cerebrospinal fluid pressure in patients with supratentorial tumors.

Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.

Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts.

Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization.

Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

The effect of glucocorticoids on CSF flow in dogs.

P2888

P304

829-836

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1997.148

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14150318

http://www.w3.org/2001/XMLSchema#string

P6179

1020183468

http://www.w3.org/2001/XMLSchema#string

P698

9062403

http://www.w3.org/2001/XMLSchema#string

P932

2063404

http://www.w3.org/2001/XMLSchema#string